Skip to content
OpenCapital
Get started

Ensysce Biosciences, Inc. ENSC Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$493.1KMiss by $206.9K
EPS-$1.29Miss by $0.44
Revenue estimate$700.0K
EPS estimate-$0.85

Next report

Aug 12, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.50

Versus estimates

Revenue

Q1 2026$961.0KMiss by $39.0KQ4 2025$1.9MBeat by $1.4M
Q3 2025$493.1KMiss by $206.9K
Q2 2025$1.4MMiss by $27.4KQ1 2025$1.3MQ4 2024$1.3MBeat by $1.1M

Diluted EPS

Q1 2026-$0.52In lineQ4 2025-$0.75Beat by $0.51
Q3 2025-$1.29Miss by $0.44
Q2 2025-$0.79Beat by $0.23Q1 2025-$1.39Beat by $1.63Q4 2024-$2.90Miss by $0.16

Ask the moment Ensysce Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Ensysce Biosciences, Inc. report Q3 2025 earnings?
Ensysce Biosciences, Inc. (ENSC) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Ensysce Biosciences, Inc.'s Q3 2025 revenue and EPS?
Ensysce Biosciences, Inc. reported revenue of $493.1K and eps of $-1.29 for Q3 2025.
Did Ensysce Biosciences, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $700.0K by $206.9K. EPS missed the consensus estimate of $-0.85 by $0.44.
How did Ensysce Biosciences, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 85.6% from $3.4M a year earlier.
Where can I find Ensysce Biosciences, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023492) and the 10-Q periodic report (0001493152-25-023498) directly on SEC EDGAR. The filing index links above go to sec.gov.